Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV-1 Transmission
NCT00099359Phase 3Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Feb 2004
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of nevirapine, lamivudine, nelfinavir in human immunodeficiency virus infection (HIV), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Feb 2004; status: completed.
02
Drugs
nevirapinelamivudinenelfinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00099359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099359.